NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.42B
This Quarter Return
-2.07%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$1.03B
AUM Growth
+$1.03B
Cap. Flow
+$74.6M
Cap. Flow %
7.28%
Top 10 Hldgs %
96.97%
Holding
14
New
4
Increased
Reduced
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VTI icon
1
Vanguard Total Stock Market ETF
VTI
$526B
$302M 29.41% 2,979,100
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$268M 26.18% 6,896,819
VGK icon
3
Vanguard FTSE Europe ETF
VGK
$26.8B
$116M 11.31% 2,101,000
INGN icon
4
Inogen
INGN
$216M
$112M 10.89% 5,419,449
OTIC
5
DELISTED
Otonomy, Inc.
OTIC
$52.2M 5.09% +2,175,025 New +$52.2M
ALDR
6
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$40.6M 3.96% 3,201,183
AKBA icon
7
Akebia Therapeutics
AKBA
$833M
$33.6M 3.27% 1,516,387
FLXN
8
DELISTED
Flexion Therapeutics, Inc.
FLXN
$32.6M 3.17% 1,783,131
ZSPH
9
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$19.9M 1.94% +506,730 New +$19.9M
TTPH
10
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$18M 1.75% 900,000
ELDN icon
11
Eledon Pharmaceuticals
ELDN
$155M
$15.5M 1.51% +1,075,037 New +$15.5M
XENT
12
DELISTED
Intersect ENT, Inc
XENT
$5.43M 0.53% +350,000 New +$5.43M
WMGI
13
DELISTED
Wright Medical Group Inc
WMGI
-585,759 Closed -$18.4M